FlowAid Medical Technologies Corp.

The use of FlowAid FA100, a novel device, for management of DFUs and ischaemic pain, evidenced by a series of case studies by Graham Bowen, Podiatry Clinical Lead, Solent NHS Trust, Southampton http://flowaid.com/use-flowaid-fa100-novel-device-manageme/ Shown at Wounds UK Annual Conference 2017 Harrogate

FlowAid Medical Technologies Inc. is pleased to announce the opening of enrollment in a clinical trial of its FlowAid FA100 SCCD in the New York Tri-State area. If you suffer from Painful Diabetic Peripheral Neuropathy (DPN), are interested in learning more and participating in this study, please contact us at [email protected] The FA100 device is a portable noninvasive electric muscle pump. The device is meant for daily home use, and does not interfere with any act...ivities or schedule. The trial will last one month and requires an introductory visit, as well as one closing visit, with the principal investigators. No medications are being evaluated as part of this study. To find out more information about the device or read some of the published Medical Journal articles written about the device, please visit www.flowaid.com or https://goo.gl/SSf2pZ

Flowaid Medical Technologies Inc. is pleased to open enrollment in a clinical trial of their Flowaid FA-100 SCCD. If you suffer from Painful Diabetic Peripheral Neuropathy and are interested in learning more; please contact [email protected]. The investigative device is a non-invasive electric muscle pump that attaches to the lower leg.

With FDA market clearance, we are happy to present to you our United States Website

U.S. Food and Drug Administration FDA clearance http://www.businesswire.com//FlowAid-Receives-FDA-Market-C

You can now download our brochure in your language - Spanish, Italian, Arabic, French, German, Dutch and English available on http://flowaid.com/worldwide/